nach oben

Journal of Neuro-Oncology

Erschienen in:

14.05.2019 | Clinical Study

Sporadic and Von-Hippel Lindau disease-associated spinal hemangioblastomas: institutional experience on their similarities and differences

verfasst von: Andrew Yousef, Martin J. Rutkowski, Can Ege Yalcin, Ozgur Can Eren, Ilay Caliskan, Tarik Tihan

Erschienen in: Journal of Neuro-Oncology | Ausgabe 3/2019

Einloggen, um Zugang zu erhalten

Abstract

Introduction

Hemangioblastomas are uncommon tumors of the central nervous system that can be seen in Von Hippel-Lindau (VHL) disease. Despite their benign histology, hemangioblastomas can cause substantial morbidity due to involvement of critical structures. In order to better understand the clinical behavior of spinal cord hemangioblastomas, we have analyzed the clinical, pathologic, radiologic characteristics and management of sporadic and VHL-associated cases at our institution.

Methods

We performed a database search to identify all spinal hemangioblastomas at our institution between 1997 and 2016. Tumor characteristics were analyzed for sporadic and VHL-associated tumors separately in order to understand the differences in groups.

Results

We included 20 patients with VHL-associated spinal hemangioblastomas, and 22 patients with sporadic spinal hemangioblastomas. VHL-associated patients were significantly younger at time of presentation compared to sporadic patients (p < 0.0025). Thirty-two patients (76.2%) presented with focal weakness, 34 (81.0%) with sensory loss, and 22 (52.4%) with pain. VHL patients were more likely to present with multiple symptoms (p < 0.001). Median follow-up time was 20.9 months, during which 17 tumors recurred. The median recurrence free interval was 44 months. There were no differences in gross total resection rates between sporadic and VHL-associated cases (p = 0.197). VHL-associated cases had a higher rate of repeat surgery for recurrence (14 patients-73.6%) compared to sporadic cases (3 patients-13.6%; p < 0.001).

Conclusion

VHL-associated spinal hemangioblastomas differ from sporadic tumors in terms of age, presenting symptoms, multifocality, and rate of recurrence. Recurrences seem to be unrelated to the extent of resection, indicating the need for life-long follow up for VHL patients.

Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A et al (2007) The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114(2):97–109CrossRefPubMedPubMedCentral

Maher E, Yates J, Harries R, Benjamin C, Harris R, Moore A et al (1990) Clinical features and natural history of von Hippel-Lindau disease. QJM 77(2):1151–1163CrossRefPubMed

Sung DI, Chang CH, Harisiadis L (1982) Cerebellar hemangioblastomas. Cancer 49(3):553–555CrossRefPubMed

Bostrom A, Hans FJ, Reinacher PC, Krings T, Burgel U, Gilsbach JM et al (2008) Intramedullary hemangioblastomas: timing of surgery, microsurgical technique and follow-up in 23 patients. Eur Spine J 17(6):882–886. https://doi.org/10.1007/s00586-008-0658-1 CrossRefPubMedPubMedCentral

Deng X, Wang K, Wu L, Yang C, Yang T, Zhao L et al (2014) Intraspinal hemangioblastomas: analysis of 92 cases in a single institution: clinical article. J Neurosurg Spine 21(2):260–269. https://doi.org/10.3171/2014.1.SPINE13866 CrossRefPubMed

Westwick HJ, Giguere JF, Shamji MF (2016) Incidence and prognosis of spinal hemangioblastoma: a surveillance epidemiology and end results study. Neuroepidemiology 46(1):14–23. https://doi.org/10.1159/000441147 CrossRefPubMed

Murota T, Symon L (1989) Surgical management of hemangioblastoma of the spinal cord: a report of 18 cases. Neurosurgery 25(5):699–708CrossRefPubMed

Yasargil M, Antic J, Laciga R, De Preux J, Fideler R, Boone S (1976) The microsurgical removal of intramedullary spinal hemangioblastomas. Report of twelve cases and a review of the literature. Surgical Neurology 1976(3):141–148.

Conway JE, Chou D, Clatterbuck RE, Brem H, Long DM, Rigamonti D (2001) Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease. Neurosurgery 48(1):55–63PubMed

10.

Filling-Katz M, Choyke P, Oldfield E, Charnas L, Patronas N, Glenn G et al (1991) Central nervous system involvement in Von Hippel-Lindau disease. Neurology 41(1):41–41CrossRefPubMed

11.

Kim TY, Yoon DH, Shin HC, Kim KN, Yi S, Oh JK et al (2012) Spinal Cord Hemangioblastomas in von Hippel-Lindau disease: management of asymptomatic and symptomatic tumors. Yonsei Med J 53(6):1073–1080CrossRefPubMedPubMedCentral

12.

Lonser RR, Glenn GM, Walther M, Chew EY, Libutti SK, Linehan WM et al (2003) von Hippel-Lindau disease. Lancet 361(9374):2059–2067. https://doi.org/10.1016/S0140-6736(03)13643-4 CrossRefPubMed

13.

Neumann H, Eggert H, Scheremet R, Schumacher M, Mohadjer M, Wakhloo A et al (1992) Central nervous system lesions in von Hippel-Lindau syndrome. J Neurol, Neurosurg Psychiatry 55(10):898–901CrossRef

14.

Lonser RR, Weil RJ, Wanebo JE, Devroom HL, Oldfield EH (2003) Surgical management of spinal cord hemangioblastomas in patients with von Hippel-Lindau disease. J Neurosurg 98(1):106–116CrossRefPubMed

15.

Mandigo CE, Ogden AT, Angevine PD, McCormick PC (2009) Operative management of spinal hemangioblastoma. Neurosurgery 65(6):1166–1177CrossRefPubMed

16.

Böhling T, Hatva E, Minna Kujala M, Claesson-Welsh L, Alitalo K, Haltia M (1996) Expression of growth factors and growth factor receptors in capillary hemangioblastoma. J Neuropathol Exp Neurol 55(5):522–527CrossRefPubMed

17.

van Leeuwaarde RS, Ahmad S, Links TP, Giles RH (1993) Von Hippel-Lindau syndrome. In: Adam MP, Ardinger HH, Pagon RA, (eds.) GeneReviews((R)). Seattle

18.

Neumann HP, Eggert HR, Weigel K, Friedburg H, Wiestler OD, Schollmeyer P (1989) Hemangioblastomas of the central nervous system: A 10-year study with special reference to von Hippel-Lindau syndrome. J Neurosurg 70(1):24–30CrossRefPubMed

19.

Kanno H, Kobayashi N, Nakanowatari S (2014) Pathological and clinical features and management of central nervous system hemangioblastomas in von Hippel-Lindau disease. J Kidney Cancer VHL 1(4):46–55. https://doi.org/10.15586/jkcvhl.2014.12 CrossRefPubMedPubMedCentral

20.

Cristante L, Herrmann H-D (1999) Surgical management of intramedullary hemangioblastoma of the spinal cord. Acta Neurochir 141(4):333–340CrossRefPubMed

21.

Roonprapunt C, Silvera VM, Setton A, Freed D, Epstein FJ, Jallo GI (2001) Surgical management of isolated hemangioblastomas of the spinal cord. Neurosurgery 49(2):321–328PubMed

22.

Xu Q-W, Bao W-M, Mao R-L, Yang G-Y (1994) Magnetic resonance imaging and microsurgical treatment of intramedullary hemangioblastoma of the spinal cord. Neurosurgery 35(4):671–676CrossRefPubMed

23.

Mehta GU, Asthagiri AR, Bakhtian KD, Auh S, Oldfield EH, Lonser RR (2010) Functional outcome after resection of spinal cord hemangioblastomas associated with von Hippel-Lindau disease: clinical article. J Neurosurg 12(3):233–242

24.

Wanebo JE, Lonser RR, Glenn GM, Oldfield EH (2003) The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease. J Neurosurg 98(1):82–94CrossRefPubMed

25.

Na JH, Kim HS, Eoh W, Kim JH, Kim JS, Kim E-S (2007) Spinal cord hemangioblastoma: diagnosis and clinical outcome after surgical treatment. J Korean Neurosurg Soc 42(6):436–440CrossRefPubMedPubMedCentral

26.

Takai K, Taniguchi M, Takahashi H, Usui M, Saito N (2010) Comparative analysis of spinal hemangioblastomas in sporadic disease and Von Hippel-Lindau syndrome. Neurol Med Chir 50(7):560–567CrossRef

27.

Park CH, Lee CH, Hyun SJ, Jahng TA, Kim HJ, Kim KJ (2012) Surgical outcome of spinal cord hemangioblastomas. J Korean Neurosurg Soc 52(3):221–227. https://doi.org/10.3340/jkns.2012.52.3.221 CrossRefPubMedPubMedCentral

Titel: Sporadic and Von-Hippel Lindau disease-associated spinal hemangioblastomas: institutional experience on their similarities and differences
verfasst von: Andrew Yousef
Martin J. Rutkowski
Can Ege Yalcin
Ozgur Can Eren
Ilay Caliskan
Tarik Tihan
Publikationsdatum: 14.05.2019
Verlag: Springer US
Erschienen in: Journal of Neuro-Oncology / Ausgabe 3/2019
Print ISSN: 0167-594X
Elektronische ISSN: 1573-7373
DOI: https://doi.org/10.1007/s11060-019-03189-w

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Frühe Alzheimertherapie lohnt sich

25.04.2024 AAN-Jahrestagung 2024 Nachrichten

Ist die Tau-Last noch gering, scheint der Vorteil von Lecanemab besonders groß zu sein. Und beginnen Erkrankte verzögert mit der Behandlung, erreichen sie nicht mehr die kognitive Leistung wie bei einem früheren Start. Darauf deuten neue Analysen der Phase-3-Studie Clarity AD.

Viel Bewegung in der Parkinsonforschung

25.04.2024 Parkinson-Krankheit Nachrichten

Neue arznei- und zellbasierte Ansätze, Frühdiagnose mit Bewegungssensoren, Rückenmarkstimulation gegen Gehblockaden – in der Parkinsonforschung tut sich einiges. Auf dem Deutschen Parkinsonkongress ging es auch viel um technische Innovationen.

Demenzkranke durch Antipsychotika vielfach gefährdet

23.04.2024 Demenz Nachrichten

Wenn Demenzkranke aufgrund von Symptomen wie Agitation oder Aggressivität mit Antipsychotika behandelt werden, sind damit offenbar noch mehr Risiken verbunden als bislang angenommen.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Introduction

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2019

Spinal location is prognostic of survival for solitary-fibrous tumor/hemangiopericytoma of the central nervous system

Gliosarcoma: distinct molecular pathways and genomic alterations identified by DNA copy number/SNP microarray analysis

Rescue bevacizumab following symptomatic pseudoprogression of a tectal glioma post-radiotherapy: a case report and review of the literature

Cost-effectiveness of tumor-treating fields added to maintenance temozolomide in patients with glioblastoma: an updated evaluation using a partitioned survival model

Satellite lesions of DNET: implications for seizure and tumor control after resection

Age-dependent copy number variations of TP53 tumour suppressor gene associated with altered phosphorylation status of p53 protein in sporadic schwannomas